Vernier Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Vernier Capital Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-131,657	Closed	-$13.1M	–	28
2018 Q2	$13.1M	Sell	131,657 -5,900	-4%	-$510K	5.92%	5
2018 Q1	$11.1M	Sell	137,557 -11,900	-8%	-$962K	6.62%	3
2017 Q4	$11.8M	Buy	149,457 +26,857	+22%	+$2.23M	6.29%	3
2017 Q3	$11.3M	Buy	122,600 +33,050	+37%	+$3.18M	8.31%	2
2017 Q2	$10.1M	Buy	+89,550	New	+$10M	5.98%	7

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vernier Capital Partners's CBPO Position: Q3 2018 in Review

Vernier Capital Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 131,657 shares — an estimated $13.1M sold.

Vernier Capital Partners first reported a position in CBPO in Q2 2017 and held it in 5 quarters. The position peaked at $13.1M in Q2 2018. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Vernier Capital Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Vernier Capital Partners sold 131,657 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $13.1M.
Vernier Capital Partners first reported a position in China Biologic Products Holdings, Inc. in Q2 2017 and held it in 5 quarters.
Vernier Capital Partners's China Biologic Products Holdings, Inc. position peaked at $13.1M in Q2 2018.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Vernier Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.